You are on page 1of 2

PubMed

U.S. National Library of Medicine


National Institutes of Health
RhoA/Rho-kinase and vascular diseases: what is the link?
Nunes KP, Rigsby CS, Webb RC.
Cell Mol Life Sci. 2010 Nov;67(22):3823-36. Epub 2010 Jul 29.
Related citations

Cytokinesis and cancer: Polo loves ROCK'n' Rho(A).


Li J, Wang J, Jiao H, Liao J, Xu X.
J Genet Genomics. 2010 Mar;37(3):159-72.
Related citations

Rho kinase (ROCK) inhibitors.


Liao JK, Seto M, Noma K.
J Cardiovasc Pharmacol. 2007 Jul;50(1):17-24.
Related citations

Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma.
Rao VP, Epstein DL.
BioDrugs. 2007;21(3):167-77.
Related citations

Development of Rho-kinase inhibitors for cardiovascular medicine.


Shimokawa H, Rashid M.
Trends Pharmacol Sci. 2007 Jun;28(6):296-302. Epub 2007 May 7.
Related citations

Rho kinase in the regulation of cell death and survival.


Shi J, Wei L.
Arch Immunol Ther Exp (Warsz). 2007 Mar-Apr;55(2):61-75. Epub 2007 Mar 9.
Related citations
Progress of the study of rho-kinase and future perspective of the inhibitor.
Tawara S, Shimokawa H.
Yakugaku Zasshi. 2007 Mar;127(3):501-14.
Related citations

Physiological role of ROCKs in the cardiovascular system.


Noma K, Oyama N, Liao JK.
Am J Physiol Cell Physiol. 2006 Mar;290(3):C661-8.
Related citations

You might also like